Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00952185 · ClinicalTrials.gov registry record · NA
Influenza Vaccine in Preventing Flu in Patients Who Have Undergone Stem Cell Transplant and in Healthy Volunteers
A NA study, sponsored by City of Hope Medical Center.
- Terminated
- Registry status
- NA
- Development phase
- 9
- Enrollment target
NCT00952185 is a NA study that was terminated before completion, run by City of Hope Medical Center. The registered enrollment target is 9 participants.
The verdict
NCT00952185, a NA study, was terminated before completion, sponsored by City of Hope Medical Center.
- TERMINATED
- Registry status
- NA
- Development phase
- 9 participants
- Enrollment target
Study Summary
RATIONALE: The influenza vaccine may help prevent flu in patients who have undergone stem cell transplant. PURPOSE: This clinical trial is studying how well the influenza vaccine works in preventing flu in patients who have undergone stem cell transplant and in healthy volunteers.
Interventions
- OTHER cytology specimen collection procedure
- PROCEDURE assessment of therapy complications
- OTHER fluorescent antibody technique
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2008-11 |
| Est. Completion | 2010-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00952185
The ClinicalTrials.gov registry entry for NCT00952185 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 9 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is City of Hope Medical Center, which has 582 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which cytology specimen collection procedure is the first listed.
NCT00952185 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00952185 about?
NCT00952185 is a clinical study titled "Influenza Vaccine in Preventing Flu in Patients Who Have Undergone Stem Cell Transplant and in Healthy Volunteers". RATIONALE: The influenza vaccine may help prevent flu in patients who have undergone stem cell transplant. PURPOSE: This clinical trial is studying how well the influenza vaccine works in preventing flu in patients who have undergone stem cell transplant and in healthy volunteers.
What is the current status of trial NCT00952185?
This trial is currently terminated. It is a NA study. The enrollment target is 9 participants. The study started on 2008-11. Estimated completion is 2010-06.
What interventions are being tested in trial NCT00952185?
The interventions under investigation include: cytology specimen collection procedure (OTHER), assessment of therapy complications (PROCEDURE), fluorescent antibody technique (OTHER).
Who is sponsoring clinical trial NCT00952185?
This trial is sponsored by City of Hope Medical Center, which has 582 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.